4-Methylmethylphenidate
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
threo-4-Methylmethylphenidate (4-MeTMP) is a
nocaine).[1] On the other hand, several other simple ring-substituted derivatives of threo-methylphenidate such as the 4-fluoro and 3-chloro compounds are more potent than methylphenidate both in efficacy as dopamine reuptake inhibitors and in animal drug discrimination assays.[2][3][4]
Legality
4-Methylmethylphenidate was banned in the UK as a
In the United States, 4-methylmethylphenidate may be considered illegal if intended for human consumption under the
federal analogue act
as a structural analog of methylphenidate.
In the United States, on September 22, 2023, the DEA filed a proposed rule for placement of ethylphenidate into Schedule I status, which would include its isomers. 4-Methylmethylphenidate is a positional isomer of ethylphenidate and thus the scheduling of ethylphenidate into Schedule I status would cause 4-methylmethylphenidate to be a Schedule I substance as well.[8]
See also
- 3-Bromomethylphenidate
- 3,4-Dichloromethylphenidate
- 4-Fluoromethylphenidate
- 4-Methylphenmetrazine
- Dexmethylphenidate
- HDMP-28
- Isopropylphenidate
- Propylphenidate
References
- PMID 10037500.
- PMID 8632426.
- PMID 11961053.
- PMID 15026075.
- ^ Methylphenidate-based NPS: A review of the evidence of use and harm. Advisory Council on the Misuse of Drugs, 31 March 2015
- ^ "Letter to Mike Penning on methylphenidate-based novel psychoactive substances". Advisory Council on the Misuse of Drugs. 25 June 2015. Retrieved 25 June 2015.
- ^ "Ministerial response to the Advisory Council on the Misuse of Drugs about 2 new methylphenidate-based substances". Home Office. 25 June 2015. Retrieved 25 June 2015.
- ^ "Federal Register :: Request Access".